The Global Molecular Diagnostics Market
|出版日期||內容資訊||英文 272 Pages, 59 Exhibits, 7 Company Profiles
|分子診斷的全球市場 The Global Molecular Diagnostics Market|
|出版日期: 2015年06月29日||內容資訊: 英文 272 Pages, 59 Exhibits, 7 Company Profiles||
分子診斷產品市場，是全球體外診斷 (IVD) 市場上成長率最高的市場區隔，其規模2014年推算為53億美元，今後以6.6％的年複合成長率發展，預計至2019年達到73億美元。儘管全球IVD產品市場是比較穩步成長，這個成長在預測期間內預測以4.2％的年複合成長率擴大。
The molecular diagnostic products market is the highest growth segment of the global in vitro diagnostics (IVDs) market valued at an estimated $5.3 billion in 2014 and projected to grow at a compound annual growth rate of 6.6% to $7.3 billion by the year 2019. This growth is forecast to occur in spite of relatively modest growth in the overall worldwide market for IVD products, which is estimated to be expanding at a compound annual rate of 4.2% for the same period. To some extent, growth of the molecular diagnostics market will occur at the expense of certain segments of the conventional diagnostic products market, including cell culture testing, immunoassay products for infectious diseases, immunoassays for cancer diagnosis and screening, and conventional products for genetic testing. Individual product segments covered in this report include molecular diagnostics for infectious disease, blood screening, genetic testing, and cancer diagnosis and screening.
Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.